Zacks Research Raises Earnings Estimates for Lam Research

Lam Research Corporation (NASDAQ:LRCX) – Equities researchers at Zacks Research lifted their Q4 2026 earnings per share estimates for shares of Lam Research in a report issued on Wednesday, August 20th. Zacks Research analyst Team now expects that the semiconductor company will earn $1.04 per share for the quarter, up from their prior estimate of $1.02. The consensus estimate for Lam Research’s current full-year earnings is $3.71 per share. Zacks Research also issued estimates for Lam Research’s FY2028 earnings at $5.43 EPS.

A number of other brokerages have also weighed in on LRCX. Wall Street Zen upgraded Lam Research from a “hold” rating to a “buy” rating in a research note on Saturday, August 2nd. Morgan Stanley upped their target price on Lam Research from $87.00 to $94.00 and gave the stock an “equal weight” rating in a research note on Thursday, July 31st. Needham & Company LLC upped their target price on Lam Research from $110.00 to $115.00 and gave the stock a “buy” rating in a research note on Thursday, July 31st. The Goldman Sachs Group initiated coverage on Lam Research in a research note on Thursday, July 10th. They issued a “buy” rating and a $115.00 target price on the stock. Finally, Oppenheimer upped their target price on Lam Research from $110.00 to $120.00 and gave the stock an “outperform” rating in a research note on Thursday, July 31st. Twenty investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $107.30.

Lam Research Stock Performance

Shares of LRCX opened at $100.08 on Friday. The stock’s 50-day simple moving average is $98.41 and its 200 day simple moving average is $84.61. The stock has a market capitalization of $126.66 billion, a price-to-earnings ratio of 24.06, a price-to-earnings-growth ratio of 1.30 and a beta of 1.65. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.55 and a current ratio of 2.21. Lam Research has a 52-week low of $56.32 and a 52-week high of $108.02.

Lam Research (NASDAQ:LRCX) last issued its quarterly earnings data on Wednesday, July 30th. The semiconductor company reported $1.33 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.21 by $0.12. The business had revenue of $5.17 billion for the quarter, compared to analysts’ expectations of $4.99 billion. Lam Research had a return on equity of 58.17% and a net margin of 29.07%.The firm’s quarterly revenue was up 33.6% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.03 EPS. Lam Research has set its Q1 2026 guidance at 1.100-1.300 EPS.

Hedge Funds Weigh In On Lam Research

Institutional investors and hedge funds have recently bought and sold shares of the stock. Pinnacle Financial Partners Inc bought a new position in Lam Research during the 1st quarter worth approximately $201,000. B. Riley Wealth Advisors Inc. bought a new position in Lam Research during the 4th quarter worth approximately $6,296,000. China Universal Asset Management Co. Ltd. grew its position in Lam Research by 27.1% during the 1st quarter. China Universal Asset Management Co. Ltd. now owns 49,505 shares of the semiconductor company’s stock worth $3,607,000 after acquiring an additional 10,565 shares during the last quarter. Cookson Peirce & Co. Inc. bought a new position in Lam Research during the 1st quarter worth approximately $607,000. Finally, First Citizens Bank & Trust Co. grew its position in Lam Research by 47.8% during the 1st quarter. First Citizens Bank & Trust Co. now owns 121,902 shares of the semiconductor company’s stock worth $8,862,000 after acquiring an additional 39,414 shares during the last quarter. 84.61% of the stock is currently owned by institutional investors.

About Lam Research

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.